Active Ingredient: ASENAPINE MALEATE
Proprietary Name: ASENAPINE MALEATE
Dosage Form; Route of Administration: TABLET; SUBLINGUAL
Strength: EQ 10MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A206107
Product Number: 002
Approval Date: Dec 10, 2020
Applicant Holder Full Name: SIGMAPHARM LABORATORIES LLC
Marketing Status:
Prescription
Patent and Exclusivity Information